🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/02/1988 | 8,14 | 8,24 | 8,09 | 8,18 | +0,41% | 1,87% | 8.573.688 |
| 01/02/1988 | 8,10 | 8,18 | 8,04 | 8,15 | +1,99% | 1,72% | 8.675.554 |
| 29/01/1988 | 7,91 | 8,00 | 7,89 | 7,99 | +1,77% | 1,43% | 9.484.819 |
| 28/01/1988 | 7,87 | 7,87 | 7,77 | 7,85 | +0,42% | 1,26% | 8.051.155 |
| 27/01/1988 | 7,93 | 8,00 | 7,76 | 7,82 | -0,51% | 3,09% | 11.101.464 |
| 26/01/1988 | 8,11 | 8,13 | 7,85 | 7,86 | -3,34% | 3,51% | 8.079.451 |
| 25/01/1988 | 8,02 | 8,16 | 7,97 | 8,13 | +2,08% | 2,40% | 5.808.226 |
| 22/01/1988 | 7,86 | 7,99 | 7,85 | 7,96 | +1,52% | 1,86% | 5.434.718 |
| 21/01/1988 | 7,77 | 7,90 | 7,63 | 7,85 | +1,72% | 3,41% | 11.163.715 |
| 20/01/1988 | 8,11 | 8,14 | 7,70 | 7,71 | -5,52% | 5,47% | 11.244.830 |
| 19/01/1988 | 8,06 | 8,24 | 8,04 | 8,16 | +0,65% | 2,55% | 9.016.992 |
| 18/01/1988 | 8,06 | 8,11 | 8,02 | 8,11 | +1,58% | 1,15% | 8.171.885 |
| 15/01/1988 | 8,19 | 8,19 | 7,98 | 7,98 | -0,25% | 2,59% | 16.413.566 |
| 14/01/1988 | 8,11 | 8,12 | 7,91 | 8,00 | -1,71% | 2,70% | 8.213.386 |
| 13/01/1988 | 8,16 | 8,24 | 8,00 | 8,14 | -1,44% | 2,92% | 10.067.717 |
| 12/01/1988 | 8,32 | 8,35 | 8,11 | 8,26 | -1,66% | 2,87% | 9.867.758 |
| 11/01/1988 | 8,22 | 8,43 | 8,22 | 8,40 | +0,63% | 2,50% | 9.356.544 |
| 08/01/1988 | 8,81 | 8,91 | 8,26 | 8,35 | -5,55% | 7,29% | 10.309.176 |
| 07/01/1988 | 8,67 | 8,87 | 8,64 | 8,84 | +1,37% | 2,68% | 7.343.755 |
| 06/01/1988 | 8,85 | 8,88 | 8,72 | 8,72 | -1,64% | 1,80% | 7.549.373 |
| 05/01/1988 | 9,01 | 9,04 | 8,84 | 8,87 | +1,75% | 2,21% | 11.088.259 |
| 04/01/1988 | 8,48 | 8,75 | 8,48 | 8,71 | +3,71% | 3,12% | 10.086.581 |
| 31/12/1987 | 8,38 | 8,42 | 8,35 | 8,40 | -0,24% | 0,87% | 5.280.034 |
| 30/12/1987 | 8,28 | 8,42 | 8,28 | 8,42 | +1,92% | 1,68% | 5.508.288 |
| 29/12/1987 | 8,28 | 8,30 | 8,18 | 8,26 | -0,24% | 1,44% | 4.040.669 |
| 28/12/1987 | 8,38 | 8,38 | 8,18 | 8,28 | -2,65% | 2,37% | 5.576.198 |
| 24/12/1987 | 8,57 | 8,57 | 8,48 | 8,51 | -0,31% | 1,00% | 1.959.970 |
| 23/12/1987 | 8,53 | 8,56 | 8,44 | 8,53 | +0,47% | 1,40% | 6.017.616 |
| 22/12/1987 | 8,59 | 8,59 | 8,42 | 8,50 | -1,08% | 2,01% | 5.623.358 |
| 21/12/1987 | 8,51 | 8,61 | 8,50 | 8,59 | +0,62% | 1,40% | 6.611.832 |